3Followers on Owler

Xenovium

Read more
Alan Watt's photo - Co-Founder & CEO of Xenovium

Co-Founder & CEO

Alan Watt

CEO Approval Rating

69/100

Founded

2013

Status

PrivateIndependent Company

Social Links

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
500-1.0K
Agree?
Funding
$0

Xenovium Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10

Xenovium Headquarters

Chesterford Research Park Little Chesterford

Saffron Walden, EnglandCB101XL

01799-530067

Driving Directions »

Xenovium Summary

ABOUT

Overview

Xenovium is a drug discovery and development platform that researches and develops projects with pharmaceutical and biotech clients. Xenovium was founded in 2013. Xenovium's headquarters is located in Saffron Walden, England, GB CB101XL. Xenovium's C...

CEO

Xenovium's Co-Founder & CEO, Alan Watt, currently has an approval rating of 69%. Xenovium's primary competitors are Ocimum Biosolutions, Strand Life Sciences & Genotypic Technology.

Acquisitions

There have been no acquisitions found related to Xenovium

Funding

Funding data cannot be found related to Xenovium

Investments

Recent investment data cannot be found related to Xenovium

Frequently Asked Questions about Xenovium

  1. When was Xenovium founded?

    Xenovium was founded in 2013
  2. Who is Xenovium's CEO?

    Xenovium's CEO is Alan Watt
  3. How much revenue does Xenovium generate?

    Xenovium generates $2M in revenue
  4. How much funding does Xenovium have?

    Xenovium has historically raised $0 in funding
  1. Where is Xenovium's headquarters?

    Xenovium's headquarters is in Saffron Walden England, GB
  2. How many employees does Xenovium have?

    Xenovium has 607 employees
  3. What sector does Xenovium operate in?

    Xenovium is in Health Care Technology
  4. Who are Xenovium's competitors?

    Xenovium's top competitors are Ocimum Biosolutions, Strand Life Sciences, Genotypic Technology

Trending Companies